Skip to main content

Find Clinical Trials

Home
Conditions
Adenocarcinoma of Lung

Clinical trial condition

Adenocarcinoma of Lung

Explore clinical trials studying Adenocarcinoma of Lung. Study availability and eligibility vary by location and protocol.

267 public trials 47 recruiting studies

Refine in advanced search Browse all conditions

Adenocarcinoma of Lung trial results

Recruiting

Lymph Node Pathologic Grading Strategy

NCT06745830

Conditions: Adenocarcinoma, Adenocarcinoma of Lung, Carcinoma, +8 more
Locations: Fudan University Shanghai Cancer Center Shanghai, Shanghai Municipality, China

View Trial Details

Recruiting

WSI Based DL for Diagnosing the IASLC Grading System of Lung Adenocarcinoma

NCT05925764

Conditions: Adenocarcinoma, Adenocarcinoma of Lung, Artificial Intelligence, +11 more
Locations: Affiliated Hospital of Zunyi Medical University Zunyi, Guizhou, China

The First Affiliated Hospital of Nanchang University Nanchang, Jiangxi, China

Ningbo HwaMei Hospital Ningbo, Zhejiang, China

View Trial Details

Recruiting

Segmentectomy for Solid-dominant Lung Cancer

NCT06634966

Conditions: Adenocarcinoma, Adenocarcinoma of Lung, Carcinoma, +9 more
Locations: Fudan University Shanghai Cancer Center Shanghai, Shanghai Municipality, China

View Trial Details

Recruiting

Improving the Intraoperative Diagnosis Accuracy of Invasiveness for Small-sized Lung Adenocarcinoma

NCT05830812

Conditions: Adenocarcinoma, Adenocarcinoma of Lung, Carcinoma, +8 more
Locations: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology Wuhan, Hubei, China

View Trial Details

Recruiting

Adjuvant Benmelstobart for Stage IB, Grade 3 Invasive Lung Adenocarcinoma

NCT06528847

Conditions: Adenocarcinoma, Adenocarcinoma of Lung, Bronchial Neoplasms, +13 more
Locations: Shanghai Pulmonary Hospital Shanghai, Shanghai Municipality, China

View Trial Details

Recruiting

Segmentectomy for Ground Glass-dominant Invasive Lung Cancer (ECTOP-1012)

NCT05717803

Conditions: Adenocarcinoma, Adenocarcinoma of Lung, Carcinoma, +9 more
Locations: Fudan University Shanghai Cancer Center Shanghai, Shanghai Municipality, China

View Trial Details

Recruiting

Pembrolizumab Plus Bevacizumab and Chemotherapy for ALK-rearranged NSCLC With Persistent 5'ALK

NCT05266846

Conditions: ALK Gene Mutation, Adenocarcinoma, Adenocarcinoma of Lung, +10 more
Locations: Hunan Cancer Hospital Changsha, Hunan, China

View Trial Details

Recruiting

Characteristics, Treatment Patterns and Outcomes for Patients With Surgically Resected Lung Cancers

NCT06255197

Conditions: Adenocarcinoma, Adenocarcinoma of Lung, Bronchial Neoplasms, +18 more
Locations: National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College Beijing, Beijing Municipality, China

View Trial Details

Recruiting

Sublobar Resection for Adenocarcinoma in Situ/Minimally Invasive Adenocarcinoma Diagnosed by Intraoperative Frozen Section (ECTOP-1019)

NCT06031181

Conditions: Adenocarcinoma, Adenocarcinoma of Lung, Carcinoma, +10 more
Locations: Fudan University Cancer Center Shanghai, Shanghai Municipality, China

View Trial Details

Recruiting

APOLLO 11, Consortium of Italian Centers Involved in Treatment of Patients With Lung Cancer Treated With Innovative Therapies: Real World Data and Translational Reaserch

NCT05550961

Conditions: Adenocarcinoma, Adenocarcinoma of Lung, Bronchial Neoplasms, +16 more
Locations: Fondazione IRCCS Istituto Nazionale dei Tumori Milan, Italy

View Trial Details